Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-05-30
2006-05-30
Carlson, Karen Cochrane (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07053050
ABSTRACT:
An agent for prophylaxis or treatment of proliferative organ diseases, chronic arthritic diseases, hypertrophic scars or keloid, comprising an erythropoietin receptor antagonist or a salt thereof.
REFERENCES:
patent: 5767078 (1998-06-01), Johnson et al.
patent: 5773569 (1998-06-01), Wrighton et al.
patent: 5885574 (1999-03-01), Elliott
patent: 10-101574 (1998-04-01), None
patent: 96/08240 (1996-03-01), None
patent: 96/20728 (1996-07-01), None
patent: 97/18805 (1997-05-01), None
patent: WO 98/10650 (1998-03-01), None
patent: 99/15648 (1999-04-01), None
patent: 00/66632 (2000-11-01), None
patent: 02/43572 (2002-06-01), None
Johnson et al. “Identification of a 13 Amino Acid Peptide Mimetic of Erythropoietin and Description of Amino Acids Critical for the Mimetic Activity of EMP1,” Biochemistry (1998), V. 37, pp. 3699-3710.
Fujita Yoshihiko
Nakamura Yukio
Yasuda Yoshiko
Carlson Karen Cochrane
Rooke Agnes
Wenderoth , Lind & Ponack, L.L.P.
Yoshiko Yasuda
LandOfFree
Preventives/remedies for proliferative organ diseases... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preventives/remedies for proliferative organ diseases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preventives/remedies for proliferative organ diseases... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3536869